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Main	Questions
ü What	prevents	active	EZR	from	associating	with	rPhe508del-CFTR		anchoring	complexes	at	the	PM?
ü Are	there	differences	between	wt-CFTR	and	rPhe508del-CFTR	interactors	at	the	PM?	
Proteomics	approach	to	identify	the	
components	of	CFTR	PM	molecular	complexes	
Selective	IP	of	CFTR	membrane	association	complexes
Conclusions
ü rPhe508del-CFTR has a much more complex network of PM interactors than wt-CFTR.
ü The innovative PM-CFTR IP approach allowed the identification of calpain 1 (CAPN1) protease as a
key player in destabilizing rPhe508del-CFTR anchoring at the PM by interfering with EZR binding.
ü We showed that the chemical inhibition of Calpain1 has potential in the pharmacological context,
namely to enhance the efficacy of current drugs as part of CF combination therapies.
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Acute chemical inhibition of CAPN1	
increases VX-809-mediated	
Phe508del-CFTR	functional rescue
Thermal-shift assay of mCherry-Flag-Phe508del-
CFTR	CFBE	cells by confocal microscopy
(Graph – quantification of fluorescence signals)
WB	analysis of EZR	and NHERF1	levels co-
precipitating with wt- or Phe508del-CFTR	at the PM
Iodide-induced HS-YFP	fluorescence decay assay of Phe508del-
CFTR	CFBE	cells treated with VX-809	(influx rates calculated by
fitting the iodide assay results to	exponential	decay curves;	
ALLM	– CAPN1	inhibitor)	
Thermal-shift assay of single-cell fluorescence signals of
mCherry-Flag-Phe508del-CFTR	CFBE	cells
Validation	of	calpain 1	
(CAPN1)	as	an	exclusive	
PM-rPhe508del	interactor		
Effect of CAPN1	on the PM	stability of rPhe508del-CFTR	
CAPN1	downregulation increases the PM	abundance and function of
VX-809-rPhe508del-CFTR	
Knockdown of CAPN1	improves	the PM	stability of rPhe508del-
CFTR	through enhanced EZR	binding
WB analysis of biotinylated cell surface proteins
(biotin pull-down – PD) and whole-cell lysates (WCL)
Iodide-induced HS-YFP	fluorescence
decay assay of Phe508del-CFTR	
CFBE	cells treated with VX-809
Number	of	high	confidence	proteins	
co-detected	with	wt-CFTR	or	
rPhe508del-CFTR	at	the	PM
Subnetwork of 22	proteins with direct interactions to	
CFTR,	EZR	or NHERF1
Druggable!
Bioinformatic analysis	of	MS	data	highlights	
CAPN1	promising	hit		
Background
Cystic fibrosis (CF) is a genetic disease caused by mutations in the gene encoding CF transmembrane conductance
regulator (CFTR), a chloride channel normally expressed at the surface of epithelial cells. The most frequent
mutation, resulting in Phe-508 deletion, causes CFTR misfolding and its premature degradation. Low temperature
or pharmacological correctors (e.g., VX-809) can partly rescue the Phe508del-CFTR processing defect and enhance
trafficking of this channel variant to the plasma membrane (PM). Nevertheless, the rescued channels have an
increased endocytosis rate, being quickly removed from the PM by the peripheral protein quality-control pathway.
We previously reported that rescued Phe508del-CFTR (rPhe508del) can be retained at the cell surface by
stimulating signaling pathways that coax the adaptor molecule ezrin (EZR) to tether rPhe508del–Na+/H+-exchange
regulatory factor-1 (NHERF1) complexes to the actin cytoskeleton, thereby averting the rapid internalization of this
channel variant. But why…?
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